Skip to Main Content

Paper Details

Randomized trial of switching from prescribed non-selective non-steroidal anti-inflammatory drugs to prescribed celecoxib: the Standard care vs. Celecoxib Outcome Trial (SCOT).
European Heart Journal
54
2017
CV death, CV disease, Celecoxib, OT, Patients, acute coronary syndrome, arthritis, celecoxib, cyclooxygenase-2, non-fatal myocardial infarction, non-fatal stroke, osteoarthritis, participants, patient, patients, rheumatoid, upper gastrointestinal complication
Author NameAffiliation
James M ScheimanUniversity of Michigan Medical School, 1500 E Medical Center Drive ann arbor
Diederick E GrobbeeJulius Center for Health Sciences and Primary Care and Julius Clinical Academic Research Organization
David M ReidUniversity of Aberdeen
  • 1 - 3

Datasets

Release 1.2